OUR EXPERIENCE OF APPLICATION OF PREPARATION OFLIVAROLIS CANDIDOSIS VULVOVAGINITISS
DOI:
https://doi.org/10.11603/24116-4944.2008.2.9591Keywords:
vaginal candidiasis, Livarol, treatment efficiencyAbstract
В последние годы отмечено возрастание частоты вагинальних кандидозов, терапия пероральными препаратами не всегда возможна, а интравагинальные препараты малоэффективны, поскольку развились грибы, резистентные к антимикотическим препаратам. Найболее эффективны препараты на основе кетоконазола, а единственной вагинальной формой його является Ливарол. Целью работы была сравнительная оценка применения антимикотического препарата фирмы „Нижфарм” (Россия) Ліварол для местной терапии вагинального кандидоза. Нами подтверджено преимущество примененияьпрепарата Ливарол (кетоконазол) для лечения кандидозных вульвовагинитов - достаточно вираженный клинический эффект за достаточно короткий прмежуток времени, удобная форма применения, незначительная частота рецидивов.
References
O.V. Grishchenko, V.L. Dudko and others. Eco-biologists aspects of epidemiology and vaginal treatment candidiasis // Reproductive health of a woman. - 2005; No. 4: p. 24-26.
Yu.P. Vdovichenko Comparative aspects of therapy vaginal candidiasis. // Health of a woman. - 2001; No. 4: Р. 4-8
V. I. Pirogov and others. The use of soft medicines forms (Hexicon and Livarol) in the treatment of pathology genitalia // reproductive health of a woman. - 2006; No. 2: Р. 68-69.
L.I. Petrukh, O.V. Pronyuk An analysis of modern antibacterial suppositories for the treatment of urogenital infections. // Bulletin of scientific research. - 2003; No. 1: Р. 116-119.
B.F. Mazorchuk et al. Modern antibacterial problemstherapy and prevention of suppurative inflammation complications in obstetrics, gynecology, surgery, their ways solution. // Bulletin of scientific research. - 2002; No. 2: Р. 74-76.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
